Dems want to focus on abortion rights. A Trump ally may have just helped.
A Texas case underscores the legal and ethical gray areas physicians have faced since the Supreme Court overturned Roe v. Wade.
A Texas case underscores the legal and ethical gray areas physicians have faced since the Supreme Court overturned Roe v. Wade.
A Texas case underscores the legal and ethical gray areas physicians have faced since the Supreme Court overturned Roe v. Wade.
A Texas case underscores the legal and ethical gray areas physicians have faced since the Supreme Court overturned Roe v. Wade.
A Texas case underscores the legal and ethical gray areas physicians have faced since the Supreme Court overturned Roe v. Wade.
A Texas case underscores the legal and ethical gray areas physicians have faced since the Supreme Court overturned Roe v. Wade.
A Texas case underscores the legal and ethical gray areas physicians have faced since the Supreme Court overturned Roe v. Wade.
A Texas case underscores the legal and ethical gray areas physicians have faced since the Supreme Court overturned Roe v. Wade.
A Texas case underscores the legal and ethical gray areas physicians have faced since the Supreme Court overturned Roe v. Wade.
A Texas case underscores the legal and ethical gray areas physicians have faced since the Supreme Court overturned Roe v. Wade.
A Texas case underscores the legal and ethical gray areas physicians have faced since the Supreme Court overturned Roe v. Wade.
District Court Judge Matthew Kacsmaryk could strike down the FDA’s decades-old decision to approve mifepristone.
District Court Judge Matthew Kacsmaryk could strike down the FDA’s decades-old decision to approve mifepristone.
District Court Judge Matthew Kacsmaryk could strike down the FDA’s decades-old decision to approve mifepristone.
The move comes as many GOP-led states are moving to limit access to abortions and transgender care.
The move comes as many GOP-led states are moving to limit access to abortions and transgender care.
There appears to be no clear strategy from either the White House or Capitol Hill to secure the funds.
There appears to be no clear strategy from either the White House or Capitol Hill to secure the funds.
The administration may have enough vaccines and therapeutics to ride out the Omicron surge, but it doesn’t currently have enough money to respond to another variant.
The administration may have enough vaccines and therapeutics to ride out the Omicron surge, but it doesn’t currently have enough money to respond to another variant.
The administration may have enough vaccines and therapeutics to ride out the Omicron surge, but it doesn’t currently have enough money to respond to another variant.
The plan will essentially federalize the current patchwork pandemic response, including spending $20 billion to speed up vaccinations.
The plan will essentially federalize the current patchwork pandemic response, including spending $20 billion to speed up vaccinations.
The plan will essentially federalize the current patchwork pandemic response, including spending $20 billion to speed up vaccinations.
Nancy Messonnier, who enraged the president with her public warning of “severe” Covid-19 consequences, is slated to reemerge as a key adviser.
Nancy Messonnier, who enraged the president with her public warning of “severe” Covid-19 consequences, is slated to reemerge as a key adviser.
Nancy Messonnier, who enraged the president with her public warning of “severe” Covid-19 consequences, is slated to reemerge as a key adviser.
Nancy Messonnier, who enraged the president with her public warning of “severe” Covid-19 consequences, is slated to reemerge as a key adviser.
Nancy Messonnier, who enraged the president with her public warning of “severe” Covid-19 consequences, is slated to reemerge as a key adviser.